Tredje AP fonden lessened its position in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 55.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 40,516 shares of the technology company’s stock after selling 50,000 shares during the quarter. Tredje AP fonden’s holdings in Veeva Systems were worth $9,044,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. HighTower Advisors LLC raised its position in Veeva Systems by 5.0% in the 4th quarter. HighTower Advisors LLC now owns 14,309 shares of the technology company’s stock valued at $3,194,000 after buying an additional 678 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its position in Veeva Systems by 3.5% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 23,658 shares of the technology company’s stock valued at $5,281,000 after buying an additional 799 shares during the last quarter. RiverFront Investment Group LLC acquired a new stake in Veeva Systems in the 4th quarter valued at approximately $558,000. North Dakota State Investment Board acquired a new stake in Veeva Systems in the 4th quarter valued at approximately $1,160,000. Finally, Accredited Investors Inc. acquired a new stake in Veeva Systems in the 4th quarter valued at approximately $589,000. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Stock Down 0.4%
NYSE:VEEV opened at $163.27 on Wednesday. The firm has a market capitalization of $26.67 billion, a price-to-earnings ratio of 30.18, a price-to-earnings-growth ratio of 0.73 and a beta of 0.92. Veeva Systems Inc. has a twelve month low of $148.05 and a twelve month high of $310.50. The stock’s 50 day moving average price is $170.17 and its two-hundred day moving average price is $206.42.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on VEEV shares. Citigroup lowered Veeva Systems from a “buy” rating to a “neutral” rating and dropped their target price for the company from $291.00 to $176.00 in a research report on Friday, April 10th. William Blair reissued an “outperform” rating on shares of Veeva Systems in a research report on Tuesday, March 10th. Oppenheimer lowered their price target on Veeva Systems from $275.00 to $225.00 and set an “outperform” rating on the stock in a research report on Monday. Stifel Nicolaus boosted their price target on Veeva Systems from $212.00 to $245.00 and gave the stock a “buy” rating in a research report on Thursday, March 5th. Finally, JPMorgan Chase & Co. lowered their price target on Veeva Systems from $330.00 to $296.00 and set an “overweight” rating on the stock in a research report on Friday, February 20th. Sixteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $276.52.
Get Our Latest Stock Report on VEEV
Insider Buying and Selling at Veeva Systems
In related news, Director Priscilla Hung sold 750 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the transaction, the director directly owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. The trade was a 18.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.
About Veeva Systems
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Stories
- Five stocks we like better than Veeva Systems
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
